ComplianceOnline

Dietary Supplement Adverse Event Reporting and Recordkeeping Requirements under the Dietary Supplement and Nonprescription Drug Consumer Protection Act

Instructor: Katherine Giannamore
Product ID: 702756
Training Level: Advanced
  • Duration: 60 Min

recorded version

$229.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Apr-2013

Training CD / USB Drive

$299.00
One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This webinar on dietary supplement adverse event reporting will explain the requirements under federal law as to when serious adverse event reports must be submitted to the FDA, what information and when it must be submitted. In addition, it will highlight the recordkeeping requirements under the law pertaining to all adverse event reports.

Why Should You Attend:

Manufacturers, packers and distributors of dietary supplements and nonprescription drugs in the United States are required under federal law to submit reports of serious adverse events. Federal law and FDA regulations dictate the precise requirements as to whom, when and how this information must be submitted. In addition, federal law sets forth the recordkeeping requirements for manufacturers, packers and distributors of dietary supplement products.

This session is designed for manufacturers and labelers of dietary supplement products and is designed to aid both domestic and foreign entities in ensuring compliance with FDA regulations. This session will cover the requirements of the Dietary Supplement and Nonprescription Drug Consumer Protection Act and accompanying FDA regulations.

Areas Covered in the Webinar:

  • Detailed overview of the Dietary Supplement and Nonprescription Drug Consumer Protection Act
  • Overview of the products and parties subject to reporting and recordkeeping requirements under federal law and FDA regulations.
  • Examination of how “serious adverse event” and “adverse event” are defined under the law and how understanding this distinction is critical to knowing when reports must be submitted to the Agency.
  • How to properly submit a serious adverse event report to the FDA, including an overview of the minimum data elements.
  • Detailed explanation of the recordkeeping requirements applicable to all responsible parties.
  • What FDA expects from manufacturers and labelers.
  • How failure to comply with the guidelines may affect the manufacturing unit.

Who Will Benefit:

  • Dietary supplement manufacturers and facilities responsible for packaging, labeling and distributing dietary supplement products
  • Regulatory Affairs
  • Documentation
  • Senior Management
  • Risk Managers
  • Legal

Instructor Profile:

Ms. Giannamore, principal attorney at the Law Office of Katherine Giannamore, P.A., helps individuals and companies resolve a wide range of regulatory issues. In addition to helping clients ensure compliance with the laws and regulations pertaining to food labeling, she serves an international clientele in the development of an array of compliant marketing materials, including websites, brochures, infomercials and more. In addition to these services, Ms. Giannamore helps companies who have been targeted as a result of non-compliance by working on their behalf to secure the release of seized goods, submission of reconditioning requests, effectuating removals from import alerts and providing responses to warning letters. In addition to foods, Ms. Giannamore provides regulatory assistance to the many different FDA-regulated industries, including medical devices, cosmetics and drugs. Katherine Giannamore is currently licensed to practice law in the State of Florida and is admitted to practice before the United States Courts of Appeals for the Third Circuit and the Eleventh Circuit.

Follow us :
Upcoming In-person Seminars by EX-FDA OFFICIALS
FDA's Regulation of Regenerative Medicine including Stem Cell Treatments

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews Write review

I am glad that I decided to join the very informative webinar. It included “Must Know” topics and covered FDA requirements for serious adverse event reporting for dietary supplements as well as clarifying the FDA definition of what constitutes a serious adverse event and how to report them. The presentation was updated to include recent developments including the Government Accountability Office report of March 2013.
- Anonymous

Best Sellers
You Recently Viewed
    Loading